Craneware CRW.L · GBp

Its shares trade on LSE under the ticker CRW.L. It has been listed since 13 September 2007. In the fiscal year to 30 June 2026, it reported revenue of $206.5m and net income of $19.8m. At that date it held total assets of $524.5m and shareholders' equity of $320.3m.

Craneware Plc engages in the provision of software and support services for the healthcare industry. The firm's Value Cycle Solutions span over five product families, which include Patient Engagement, Charge Capture & Pricing, Coding Integrity, Cost Analytics, and Revenue Collection & Retention. Its Patient Engagement solutions include InSight Medical Necessity, Trisus Patient Payment and Patient Charge Estimator. The Charge Capture & Pricing solutions include Chargemaster Toolkit Discovery Viewer; Physician Revenue Toolkit, Physician Management Toolkit and Physician Revenue Toolkit-Corporate; Pricing Analyzer; Reference Plus; Pharmacy ChargeLink; Supplies ChargeLink, and Supporting Modules. Its Coding Integrity solutions include Trisus Claims Informatics and Bill Analyzer. Its Revenue Recovery & Retention solutions include InSight Audit and InSight Denials. The company also offers professional services.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. William WhitehornNon-Executive Chairman of the Board$94,463
• Mr. Keith NeilsonChief Executive Officer, Co-Founder, Executive Director, since 1999$809,055
• Mr. Craig PrestonChief Financial Officer, Company Secretary, Executive Director, since 2008$636,377
• Ms. Isabel UrquhartChief People Officer, Executive Director, since 2022$424,967
• Mr. Alistair ErskineNon-Executive Independent Director$54,216
• Mr. David KempSenior Non-Executive Independent Director$58,826
• Ms. Anne MccuneNon-Executive Independent Director$54,216
• Ms. Tamra MinnierNon-Executive Independent Director
• Ms. Caroline FordeInvestor Relations, since 2020

Overall

31

Environment

35

Social

37

Governance

22

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.